A recent meta-analysis on the prognostic value of LAG3 in cancer proposed LAG3 expression to be associated with better overall survival, with a trend towards higher benefit in early stage cancer than in metastatic disease [30]. The gene discussed is LAG3; the disease is metastatic neoplasm.